bluebird bio, Inc. Finance Lease, Interest Expense
bluebird bio, Inc. reported Finance Lease, Interest Expense of $1.62 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:FinanceLeaseInterestExpense · last filed 2025-05-14
- bluebird bio, Inc. finance lease, interest expense for the quarter ending 2025-03-31 was $1.62M, a 62.64% decline year-over-year.
- bluebird bio, Inc. finance lease, interest expense for the quarter ending 2024-12-31 was $1.74M, a 56.70% decline year-over-year.
- bluebird bio, Inc. finance lease, interest expense for the quarter ending 2024-09-30 was $2.36M, a 45.16% decline year-over-year.
- bluebird bio, Inc. finance lease, interest expense for the quarter ending 2024-06-30 was $2.71M, a 27.73% decline year-over-year.
- bluebird bio, Inc. finance lease, interest expense for fiscal 2024 was $11.16M, a 31.72% decline from fiscal 2023.
- bluebird bio, Inc. finance lease, interest expense for fiscal 2023 was $16.35M, a 158.54% increase from fiscal 2022.
- bluebird bio, Inc. finance lease, interest expense for fiscal 2022 was $6.32M.
- bluebird bio, Inc. finance lease, interest expense for fiscal 2020 was $0.00.
| Period end | Finance Lease, Interest Expense 3 month | Finance Lease, Interest Expense 6 month | Finance Lease, Interest Expense 9 month | Finance Lease, Interest Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.62M 10-Q · filed 2025-05-14 | $3.37M derived: sum of 2 quarters · filed 2025-05-14 | $5.73M derived: sum of 3 quarters · filed 2025-05-14 | $8.44M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $4.11M derived: sum of 2 quarters · filed 2025-03-27 | $6.82M derived: sum of 3 quarters · filed 2025-03-27 | $11.16M 10-K · filed 2025-03-27 |
| 2024-09-30 | $2.36M 10-Q · filed 2024-11-14 | $5.07M derived: sum of 2 quarters · filed 2024-11-14 | $9.42M 10-Q · filed 2024-11-14 | $13.44M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $2.71M 10-Q · filed 2024-09-27 | $7.06M 10-Q · filed 2024-09-27 | $11.08M derived: sum of 3 quarters · filed 2025-05-14 | $15.39M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $4.35M 10-Q · filed 2025-05-14 | $8.37M derived: sum of 2 quarters · filed 2025-05-14 | $12.68M derived: sum of 3 quarters · filed 2025-05-14 | $16.43M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $8.33M derived: sum of 2 quarters · filed 2025-03-27 | $12.08M derived: sum of 3 quarters · filed 2025-03-27 | $16.35M 10-K · filed 2025-03-27 |
| 2023-09-30 | $4.31M 10-Q · filed 2024-11-14 | $8.06M derived: sum of 2 quarters · filed 2024-11-14 | $12.33M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $3.75M 10-Q · filed 2024-09-27 | $8.02M 10-Q · filed 2024-09-27 | ||
| 2023-03-31 | $4.27M 10-Q · filed 2024-09-13 | |||
| 2022-12-31 | $6.32M 10-K · filed 2024-09-13 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2018-12-31 | $15.50M 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $11.40M 10-K · filed 2020-02-18 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-21 |